Saturday, 10 October 202611:05 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

GLP-1–Based Therapies Significantly Reduce Inflammation in Cardiometabolic Disease: Meta-Analysis

Image: Business Medical Dialogues. Rights remain with the publisher.

China: Research presented at the International Congress on Obesity showed that incretin-based therapies (GLP-1 receptor agonists) significantly lower high-sensitivity C-reactive protein (hs-CRP), a...

Read the full report on Business Medical Dialogues

Story file

Section
Health
Topics
Health alerts
First reported by
Business Medical Dialogues
Reporter
medha baranwal
Published
Saturday, 10 October 2026, 9:15 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all